IFNA1 and neoplasm: Previous reports have established that common sets of IFN-γ– and T cell-associated inflammatory genes could predict responsiveness to PD-1 blockade across different tumor types.16 These signatures, made up of 6 and 18 genes, respectively, were further called IFN signature and expanded immune gene (EIG) signature.